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In the **Introduction**, the sentence "The IDF guidelines recommend starting with a long-acting basal insulin analog, with pre-mixed insulin for those with higher HbA1C" should read:

"The IDF guidelines recommend starting with a long-acting basal insulin, and suggest starting with pre-mixed insulins for those with a higher starting HbA1C."
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